These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38810198)

  • 1. Omalizumab for the Treatment of Multiple Food Allergies. Reply.
    Wood RA; Togias A; Chinthrajah RS
    N Engl J Med; 2024 May; 390(20):1936. PubMed ID: 38810198
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab for the Treatment of Multiple Food Allergies.
    Hui Shi En E; Cheng-Chung Wei J
    N Engl J Med; 2024 May; 390(20):1936. PubMed ID: 38810197
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of omalizumab in the treatment of food allergy and anaphylaxis.
    Lieberman JA; Chehade M
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):78-84. PubMed ID: 23065311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylaxis to vapors of roasting chicken controlled by omalizumab.
    Barnig C; Hilger C; Muti D; Blaumeiser M; Purohit A; Hentges F; de Blay F
    J Investig Allergol Clin Immunol; 2012; 22(6):439-40. PubMed ID: 23101190
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-IgE therapy: clinical utility beyond asthma.
    Casale TB; Stokes J
    J Allergy Clin Immunol; 2009 Apr; 123(4):770-1.e1. PubMed ID: 19348915
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-IgE treatment: an update.
    Babu KS; Arshad SH; Holgate ST
    Allergy; 2001 Dec; 56(12):1121-8. PubMed ID: 11736740
    [No Abstract]   [Full Text] [Related]  

  • 7. Omalizumab in the treatment of eosinophilic esophagitis and food allergy.
    Rocha R; Vitor AB; Trindade E; Lima R; Tavares M; Lopes J; Dias JA
    Eur J Pediatr; 2011 Nov; 170(11):1471-4. PubMed ID: 21809010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in human basophils IgE-mediated stimulation by omalizumab: a role for membrane FcγRs?
    Chirumbolo S; Olivieri M
    J Allergy Clin Immunol; 2014 May; 133(5):1493-4. PubMed ID: 24642141
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-IgE--emerging opportunities for Omalizumab.
    Babu KS; Polosa R; Morjaria JB
    Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
    Fairley JA; Baum CL; Brandt DS; Messingham KA
    J Allergy Clin Immunol; 2009 Mar; 123(3):704-5. PubMed ID: 19152970
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.
    Macglashan DW; Saini SS
    J Allergy Clin Immunol; 2013 Oct; 132(4):906-11.e1-4. PubMed ID: 23791510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply: To PMID 23791510.
    MacGlashan D
    J Allergy Clin Immunol; 2014 May; 133(5):1494-5. PubMed ID: 24642142
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of omalizumab in patients with food allergy.
    Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
    Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
    Lang DM
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
    [No Abstract]   [Full Text] [Related]  

  • 16. Omalizumab for patients with severe and therapy-refractory atopic eczema?
    Andres C; Belloni B; Mempel M; Ring J
    Curr Allergy Asthma Rep; 2008 May; 8(3):179-80. PubMed ID: 18589835
    [No Abstract]   [Full Text] [Related]  

  • 17. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
    Casale TB;
    Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab?
    Kutlu A; Karabacak E; Aydin E; Ozturk S; Bozkurt B
    Hum Exp Toxicol; 2014 Aug; 33(8):882-5. PubMed ID: 24203455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab treatment in severe adult atopic dermatitis.
    Thaiwat S; Sangasapaviliya A
    Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.
    Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D
    Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.